Skip to content
healthcare.dev

Bosentan

NDC 68180-340, Bosentan, tablet, for suspension, from Lupin Pharmaceuticals, Inc..

Product NDC
68180-340
Status
Listed
Labeler
Lupin Pharmaceuticals, Inc.
Dosage form
TABLET, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213154
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68180-340 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BOSENTAN32 mg/1

Pharmacologic classes

Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A Inducers [MoA]; Endothelin Receptor Antagonist [EPC]; Endothelin Receptor Antagonists [MoA]

Package NDCNDC-11Package
68180-340-13681800340134 BLISTER PACK in 1 CARTON (68180-340-13) / 14 TABLET, FOR SUSPENSION in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/540b6f6a-79f3-4681-8c2a-268cf7cecbc9

Use it

Look up 68180-340 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68180-340 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68180-340. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.